Trial Profile

Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 16 Jan 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

17 Sep 2018 According to a Boehringer Ingelheim media release, Professor Arschang Valipour was Lead Investigator for the OTIVACTO trial.
17 Sep 2018 According to a Boehringer Ingelheim media release, data from the trial presented at the European Respiratory Society (ERS) International Congress 2018.
17 Sep 2018 Results (n=7443) published in the Boehringer Ingelheim Media Release

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com